Tender Description
Notice type: Solicitation · NAICS 541714 · PSC AN12 Amendment 02 is to issue minor changes to solicitation, 75N91023R00024, for the PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers, Preclinical Services for Biopharmaceutical Product Development and Manufacturing, and Toxicology and Pharmacology Testing. See attached for additional details.
- Country
- United States
- Published
- 16 Sept 2024
- Closing date
- 28 Feb 2023
- Procedure
- Solicitation
